1. Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development. Issue 6 (30th November 2022) Authors: Hicks, Dustin; Baehr, Carly; Silva-Ortiz, Pedro; Khaimraj, Aaron; Luengas, Diego; Hamid, Fatima A.; Pravetoni, Marco Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders. Issue 4 (3rd April 2019) Authors: Robinson, Christine; Baehr, Carly; Schmiel, Shirdi E.; Accetturo, Claudia; Mueller, Daniel L.; Pravetoni, Marco Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 4(2019) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biologics to treat substance use disorders: Current status and new directions. Issue 12 (1st December 2016) Authors: Pravetoni, Marco Journal: Human vaccines & immunotherapeutics Issue: Volume 12:Issue 12(2016) Page Start: 3005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Countermeasures for Preventing and Treating Opioid Overdose. Issue 3 (29th November 2020) Authors: France, Charles P.; Ahern, Gerard P.; Averick, Saadyah; Disney, Alex; Enright, Heather A.; Esmaeli‐Azad, Babak; Federico, Arianna; Gerak, Lisa R.; Husbands, Stephen M.; Kolber, Benedict; Lau, Edmond Y.; Lao, Victoria; Maguire, David R.; Malfatti, Michael A.; Martinez, Girardo; Mayer, Brian P.; Pr... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 3(2021) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of vaccines to treat opioid use disorders and reduce incidence of overdose. (1st November 2019) Authors: Pravetoni, Marco; Comer, Sandra D. Journal: Neuropharmacology Issue: Volume 158(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats. Issue 11 (2nd November 2021) Authors: Crouse, Bethany; Zhang, Li; Robinson, Christine; Ban, Yuguang; Vigliaturo, Jennifer R; Roy, Sabita; Pravetoni, Marco Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 11(2021) Page Start: 4383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunotherapeutic strategies for treating opioid use disorder and overdose. (2nd January 2023) Authors: Luba, Rachel; Martinez, Suky; Jones, Jermaine; Pravetoni, Marco; Comer, Sandra D Journal: Expert opinion on investigational drugs Issue: Volume 32:Number 1(2023) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity. Issue 30 (19th June 2020) Authors: Gradinati, Valeria; Baruffaldi, Federico; Abbaraju, Santhi; Laudenbach, Megan; Amin, Rasidul; Gilger, Brian; Velagaleti, Poonam; Pravetoni, Marco Journal: Vaccine Issue: Volume 38:Issue 30(2020) Page Start: 4704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Potential unintended consequences of class-wide drug scheduling based on chemical structure: A cautionary tale for fentanyl-related compounds. (1st April 2021) Authors: Comer, Sandra D.; Pravetoni, Marco; Coop, Andrew; Baumann, Michael H.; Cunningham, Christopher W. Journal: Drug and alcohol dependence Issue: Volume 221(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Issue 23 (20th May 2022) Authors: Hamid, Fatima A.; Marker, Cheryl L.; Raleigh, Michael D.; Khaimraj, Aaron; Winston, Scott; Pentel, Paul R.; Pravetoni, Marco Journal: Vaccine Issue: Volume 40:Issue 23(2022) Page Start: 3244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗